← Leaderboards
Dillon Matthew Voss
State University New York Stony Brook
$174,867
Attributed
$174,867
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $54.5K · FY2022–25$100K$75K$50K$25K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$174,867 · 1
By mechanism
F30$174,867 · 1
Top collaborators
No co-investigators on record.
Most similar at State University New York Stony Brook
Same institution · by research overlap
- Jarrod B French$5,158,109
- Mirjana Maletic-Savatic$7,420,032
- David G Thanassi$14,588,352
- Laurie T Krug$2,581,773
- Roger A Johnson$1,553,991
Others in their field
Other Rising Stars on “Glucose Metabolism”
- Russell Jones · Van Andel Research Institute$3,618,959
- Simon Vu · Equator Therapeutics, Inc.$3,142,274
- Marianna Sadagurski · Wayne State University$2,991,869
- Yue Wang · Florida State University$2,782,476
- Linda E May · East Carolina University$2,622,578
- Lidia Minguez Alarcon · Brigham And Women'S Hospital$2,572,266
Research focus
Glucose MetabolismAlternative SplicingAntisense OligonucleotidesAmino Acid TransporterApoptosisAnabolismBay 54-9085BevacizumabCarbonAntisense Oligonucleotide TherapyCasp3 GeneCell LineClinical TrialsCombined Modality TherapyDependenceDesignEffective TherapyEnzyme InhibitionEnzymesExtracellularFutureGenesGlucoseGlycolysis
Grant awards (4)
Inducing PKM splice-switching with antisense oligonucleotides as an approach to treat hepatocellular carcinoma$54,538
F30 · FY2025 · CA · contact PI
Inducing PKM splice-switching with antisense oligonucleotides as an approach to treat hepatocellular carcinoma$41,277
F30 · FY2024 · CA · contact PI
Inducing PKM splice-switching with antisense oligonucleotides as an approach to treat hepatocellular carcinoma$39,997
F30 · FY2023 · CA · contact PI
Inducing PKM splice-switching with antisense oligonucleotides as an approach to treat hepatocellular carcinoma$39,055
F30 · FY2022 · CA · contact PI